Skip to main
LBRX
LBRX logo

LBRX Earnings Dates & Reports

LBRX Most Recent Earnings

Report DateNov 6, 2025
Period EndingQ3 2025
Est. EPS-$0.57
Actual EPS-$0.61
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

LBRX Earnings per Share (EPS) History

Signup for full access
Browse free

LBRX Latest Earnings

The value each LBRX share was expected to gain vs. the value each share gained.

LBRX reported its most recent earnings on Nov 6, 2025 for Q3 2025, posting earnings per share (EPS) of -$0.61. This exceeded analysts' expectations of -$0.57 by 7.02%, marking a Miss.

For comparison, LB Pharmaceuticals Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 02/15/2026, with analysts projecting an EPS of -$0.35.

LBRX Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Feb 19, 2026
-$0.35Next earnings call Feb. 15, 2026
Q3 2025Nov 6, 2025
-$0.57-$0.61+7.02%
DeckReportListen

LBRX Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the LB Pharmaceuticals Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Nov 6, 2025

LBRX Earnings FAQs

LBRX last reported earnings on Nov 6, 2025 for Q3 2025, posting an EPS of -$0.61, which Miss the estimate of -$0.57 by 7.02%.

For Q3 2025, LBRX reported an EPS of -$0.61, missing analysts' estimate of -$0.57 by 7.02%.

For Q3 2025, LBRX Miss expectations with an actual EPS of -$0.61 vs. an estimated EPS of -$0.57.

Following the last earnings report on Nov 6, 2025, LBRX's stock price moved — from — to —.

The next LBRX earnings call is scheduled for Feb. 15, 2026, where executives will discuss financial results and outlook.

LB Pharmaceuticals Inc (LBRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.